Efficacy and safety of adding immune checkpoint inhibitors to first-line standard therapy for recurrent or advanced cervical cancer: a meta-analysis of phase 3 clinical trials - Zhang, Xinmiao; Shen, Jinhai; Huang, Mengfan; Li, Rongxia (Frontiers in Immunology, 2024)